Biological Products, (No Diagnostic Substances) · NV · CIK 1919246
Pelthos Therapeutics commercializes innovative therapeutic products, including FDA-approved ZELSUVMI, XEPI, and XEGLYZE
Comparable business profile · signals at a glance
In the 90 days to Nov 25, 2025: 1 sold $280K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 25, 2025 | Friedberg Ezra MDirector | Sell | 5,999 | $28.00 | $168K |
| Nov 25, 2025 | Friedberg Ezra MDirector | Sell | 2,000 | $28.14 | $56K |
| Nov 25, 2025 | Friedberg Ezra MDirector | Sell | 2,000 | $28.01 | $56K |
| Nov 25, 2025 | Friedberg Ezra MDirector | Sell | 1 | $28.50 | $29 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.